For years, driving school instructors in South Florida helped students learn the rules of the road in the language they ...
Eli Lilly and Company today announced results from the Phase 3 LIBRETTO-432 clinical trial of Retevmo (selpercatinib) as adjuvant therapy versus placebo in patients with early-stage (IB-IIIA) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results